Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate
Dexmedetomidine is an 𝛼2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe t...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2010-01-01
|
| Series: | International Journal of Pediatrics |
| Online Access: | http://dx.doi.org/10.1155/2010/825079 |
| id |
doaj-3d827f6f1ff0479c9df64d575bbe1b6a |
|---|---|
| record_format |
Article |
| spelling |
doaj-3d827f6f1ff0479c9df64d575bbe1b6a2020-11-24T23:31:42ZengHindawi LimitedInternational Journal of Pediatrics1687-97401687-97592010-01-01201010.1155/2010/825079825079Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended RateBryan A. Max0Keira P. Mason1Department of Anesthesia, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115 , USADepartment of Anesthesia, Perioperative, and Pain Medicine, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USADexmedetomidine is an 𝛼2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe the hemodynamic, respiratory, and sedative effects of this overdose.http://dx.doi.org/10.1155/2010/825079 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Bryan A. Max Keira P. Mason |
| spellingShingle |
Bryan A. Max Keira P. Mason Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate International Journal of Pediatrics |
| author_facet |
Bryan A. Max Keira P. Mason |
| author_sort |
Bryan A. Max |
| title |
Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate |
| title_short |
Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate |
| title_full |
Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate |
| title_fullStr |
Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate |
| title_full_unstemmed |
Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate |
| title_sort |
extended infusion of dexmedetomidine to an infant at sixty times the intended rate |
| publisher |
Hindawi Limited |
| series |
International Journal of Pediatrics |
| issn |
1687-9740 1687-9759 |
| publishDate |
2010-01-01 |
| description |
Dexmedetomidine is an 𝛼2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe the hemodynamic, respiratory, and sedative effects of this overdose. |
| url |
http://dx.doi.org/10.1155/2010/825079 |
| work_keys_str_mv |
AT bryanamax extendedinfusionofdexmedetomidinetoaninfantatsixtytimestheintendedrate AT keirapmason extendedinfusionofdexmedetomidinetoaninfantatsixtytimestheintendedrate |
| _version_ |
1725536306246713344 |